Products for Research Use Only
RegisterLogin

Tobevibart

CAT: 0804-HY-P990015-01Size: 1 mgDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P990015-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Tobevibart (VIR-3434) is a human IgG1 lambda monoclonal antibody against hepatitis B virus (HBV) surface antigen (HBsAg). Tobevibart shows potent neutralization against HBsAg from all HBV genotypes in vitro and inhibits viral entry of HBV and hepatitis delta virus (HDV). Recommend Isotype Controls: Human IgG1 lambda2, Isotype Control.
CAS Number
2645440-65-7
Product Name Alternative
VIR-3434
UNSPSC
12352203
Target
HBV
Type
Inhibitory Antibodies
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/tobevibart.html
Purity
99.83
Solubility
H2O
Smiles
[Tobevibart]
Molecular Weight
(143.234 kDa)
References & Citations
[1]Jiayi Zhou, et al. Therapy with murinized tobevibart and elebsiran is efficacious in a liver-chimeric mouse model of HDV infection. JHEP Reports. 22 March 2025, 101400.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 3

Alternative Products

CatalogName
T80970-01Tobevibart
GTR18333567-01Tobevibart Antibody
MBS1580262-01Research Grade Tobevibart
E55B1019Tobevibart (Reference antibody)
ICH5931-10mgTobevibart Biosimilar - Research Grade
GTR18696595-01Tobevibart Human Monoclonal Antibody
GTR18780816-01(Tobevibart) Biosimilar Reference Antibody
A136202Tobevibart Biosimilar (Monoclonal, IgG1-lambda)
PX-TA2089-01Tobevibart Biosimilar - Anti-HBV mAb - Research Grade
RA0298-01Tobevibart (Biosimilar Reference Antibody) (Human Papillomavirus Envelope Protein)

Popular Products